Chemical Namefostemsavir
Dosage FormTablet (oral; 600mg)
Drug ClassAntivirals
CompanyViiV Healthcare
Approval Year2020


  • For the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations.
Last updated on 12/3/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Rukobia (fostemsavir) Prescribing Information.2020ViiV Healthcare, Research Triangle Park, NC